# A Study of Nasal Glucagon in Participants With Type 1 Diabetes Mellitus

> **NCT03339453** · PHASE1 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 70 (actual)

## Conditions studied

- Hypoglycemia
- Diabetes Mellitus, Type 1

## Interventions

- **DRUG:** Nasal Glucagon
- **DRUG:** Intramuscular Glucagon

## Key facts

- **NCT ID:** NCT03339453
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-11-10
- **Primary completion:** 2017-12-17
- **Final completion:** 2018-01-13
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2019-09-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03339453

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03339453, "A Study of Nasal Glucagon in Participants With Type 1 Diabetes Mellitus". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03339453. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*